On 24 February 2026, EC Healthcare (2138) disclosed additional information related to its Annual Report for the year ended 31 March 2025, focusing on the Share Award Scheme adopted on 27 June 2016. According to the announcement, the maximum cumulative nominal value of shares granted under the scheme will not exceed 10% of the company’s total issued share capital at any point in time.

Since its adoption, 7.20 million award shares have been granted and subsequently either vested or forfeited, leaving no outstanding unvested shares. At 31 March 2025, a total of 111.32 million shares were available for issue under the scheme. The vesting schedule is determined at the Board’s discretion, subject to a vesting period of not less than 12 months, and no payment is required for applying or accepting the awards.